TG Therapeutics Inc (TGTX)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.42 | 0.42 | 0.26 | 0.27 | 0.30 | 0.30 | 0.44 | 0.49 | 0.37 | 0.33 | 0.27 | 0.22 | 0.18 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.08 | 0.29 |
| Debt-to-capital ratio | 0.52 | 0.56 | 0.37 | 0.39 | 0.38 | 0.38 | 0.71 | 0.78 | 0.55 | 0.41 | 0.35 | 0.28 | 0.22 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.10 | 1.05 |
| Debt-to-equity ratio | 1.10 | 1.27 | 0.58 | 0.63 | 0.62 | 0.60 | 2.42 | 3.52 | 1.21 | 0.71 | 0.53 | 0.39 | 0.28 | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.11 | — |
| Financial leverage ratio | 2.60 | 3.05 | 2.26 | 2.33 | 2.05 | 2.01 | 5.46 | 7.19 | 3.30 | 2.17 | 1.95 | 1.78 | 1.60 | 1.32 | 1.26 | 1.23 | 1.20 | 1.60 | 1.52 | — |
Based on the provided data, we can see the trend of solvency ratios for TG Therapeutics Inc over the period from March 31, 2020, to December 31, 2024. Here is a comprehensive analysis of the solvency ratios:
1. Debt-to-assets ratio: This ratio indicates the proportion of the company's assets financed by debt. TG Therapeutics Inc's debt-to-assets ratio has fluctuated over the period, ranging from a low of 0.00 in March 31, 2021, to a high of 0.49 in March 31, 2023. Generally, a lower debt-to-assets ratio indicates a lower financial risk for the company.
2. Debt-to-capital ratio: This ratio shows the proportion of the company's capital that is financed by debt. TG Therapeutics Inc's debt-to-capital ratio has shown fluctuations as well, with the lowest value of 0.00 in March 31, 2021, and the highest value of 0.78 in March 31, 2023. A lower debt-to-capital ratio implies a lower dependency on debt for financing.
3. Debt-to-equity ratio: The debt-to-equity ratio reflects the company's degree of leverage and financial risk. TG Therapeutics Inc had an absence of data in March 31, 2020, but the ratio ranged from 0.00 in March 31, 2021, to 3.52 in March 31, 2023. A higher debt-to-equity ratio suggests higher financial risk and leverage.
4. Financial leverage ratio: This ratio compares the company's total assets to its equity capital and indicates the level of financial risk the company bears. TG Therapeutics Inc's financial leverage ratio increased from 1.52 in June 30, 2020, to 7.19 in March 31, 2023, before decreasing to 2.60 in December 31, 2024. Higher financial leverage ratios imply higher risk and potential financial distress.
In summary, TG Therapeutics Inc experienced fluctuations in its solvency ratios over the period, with some ratios showing improvement or deterioration in the company's financial risk and leverage. Investors and stakeholders should closely monitor these ratios to assess the company's ability to meet its financial obligations and manage its debt effectively.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 21.46 | 0.09 | 13.84 | 4.08 | 1.64 | -1.45 | -15.36 | -15.71 | -18.92 | -27.80 | -36.41 | -50.35 | -61.15 | -57.88 | -52.82 | -44.48 | -43.22 | -32.40 | -29.12 | -32.31 |
TG Therapeutics Inc's interest coverage ratio has shown a significant improvement over the last few years. The interest coverage ratio, which was negative in the range of -32.31 to -61.15 from March 2020 to December 2021, indicating that the company was not generating enough operating income to cover its interest expenses.
However, starting from March 2022, there was a noticeable positive trend in the interest coverage ratio, with values improving to the positive range of 1.64 to 21.46 by December 2024. This indicates that the company's operating income has increased sufficiently to cover its interest expenses.
The increasing trend in the interest coverage ratio highlights an improvement in the company's ability to meet its interest obligations, which is a positive sign for creditors and investors. It suggests a healthier financial position and reduced risk of financial distress due to interest payments.